343 related articles for article (PubMed ID: 12610718)
41. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W
Curr Med Res Opin; 2007 Oct; 23(10):2313-23. PubMed ID: 17706003
[TBL] [Abstract][Full Text] [Related]
42. Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period.
Weiden PJ; Du Y; Liu CC; Stanford AD
CNS Spectr; 2019 Aug; 24(4):419-425. PubMed ID: 29941057
[TBL] [Abstract][Full Text] [Related]
43. Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics.
Hwang TJ; Lo WM; Chan HY; Lin CF; Hsieh MH; Liu CC; Liu CM; Hwu HG; Kuo CH; Chen WJ
J Clin Psychopharmacol; 2015 Dec; 35(6):635-44. PubMed ID: 26488675
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study.
Mallikaarjun S; Kane JM; Bricmont P; McQuade R; Carson W; Sanchez R; Forbes RA; Fleischhacker WW
Schizophr Res; 2013 Oct; 150(1):281-8. PubMed ID: 23890595
[TBL] [Abstract][Full Text] [Related]
45. Intramuscular aripiprazole in the acute management of psychomotor agitation.
De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
[TBL] [Abstract][Full Text] [Related]
46. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.
Kane JM; Crandall DT; Marcus RN; Eudicone J; Pikalov A; Carson WH; Swyzen W
Schizophr Res; 2007 Sep; 95(1-3):143-50. PubMed ID: 17644313
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.
Kasper S; Lerman MN; McQuade RD; Saha A; Carson WH; Ali M; Archibald D; Ingenito G; Marcus R; Pigott T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):325-37. PubMed ID: 14609439
[TBL] [Abstract][Full Text] [Related]
48. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
[TBL] [Abstract][Full Text] [Related]
49. Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients.
Crossman AM; Lindenmayer JP
J Clin Psychiatry; 2006 Jul; 67(7):1158-9. PubMed ID: 16889465
[No Abstract] [Full Text] [Related]
50. Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.
Fagiolini A; Brugnoli R; Di Sciascio G; De Filippis S; Maina G
Expert Opin Pharmacother; 2015 Apr; 16(5):727-37. PubMed ID: 25672664
[TBL] [Abstract][Full Text] [Related]
51. Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.
Bergmann F; Zacher A; Nass A; Urban R; Werner C; Spevakné-Göröcs T; Kungel M; Ebrecht M; Modell S
Pharmacopsychiatry; 2009 May; 42(3):101-8. PubMed ID: 19452378
[TBL] [Abstract][Full Text] [Related]
52. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
[TBL] [Abstract][Full Text] [Related]
53. Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel.
Sullivan G; Bienroth M; Jones M; Millar H; Ratna L; Taylor D
Curr Med Res Opin; 2007 Jul; 23(7):1733-44. PubMed ID: 17588303
[TBL] [Abstract][Full Text] [Related]
54. Aripiprazole: a review of its use in the management of schizophrenia in adults.
Croxtall JD
CNS Drugs; 2012 Feb; 26(2):155-83. PubMed ID: 22296317
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
56. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
Kane JM; Sanchez R; Perry PP; Jin N; Johnson BR; Forbes RA; McQuade RD; Carson WH; Fleischhacker WW
J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
58. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
[TBL] [Abstract][Full Text] [Related]
59. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
60. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
